HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia Di Giacomo Selected Research

Polycyclic Sesquiterpenes

6/2022Sorafenib Chemosensitization by Caryophyllane Sesquiterpenes in Liver, Biliary, and Pancreatic Cancer Cells: The Role of STAT3/ABC Transporter Axis.
11/2021Role of Caryophyllane Sesquiterpenes in the Entourage Effect of Felina 32 Hemp Inflorescence Phytocomplex in Triple Negative MDA-MB-468 Breast Cancer Cells.
10/2020Chemopreventive Potential of Caryophyllane Sesquiterpenes: An Overview of Preliminary Evidence.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia Di Giacomo Research Topics

Disease

7Neoplasms (Cancer)
06/2022 - 12/2018
4Hepatocellular Carcinoma (Hepatoma)
06/2022 - 01/2018
4Cholangiocarcinoma
06/2022 - 01/2018
2Liver Neoplasms (Liver Cancer)
01/2019 - 01/2018
1Pancreatic Neoplasms (Pancreatic Cancer)
06/2022
1Adenocarcinoma
06/2022
1Breast Neoplasms (Breast Cancer)
11/2021
1Triple Negative Breast Neoplasms
11/2021
1Immune System Diseases (Immune Disorders)
08/2020
1Wounds and Injuries (Trauma)
08/2020
1Biliary Tract Neoplasms (Biliary Tract Cancer)
01/2020
1Hyperglycemia
08/2019
1Hypoxia (Hypoxemia)
08/2018
1Infections
08/2018
1Human Influenza (Influenza)
01/2018
1Hepatoblastoma
01/2018
1Cognitive Dysfunction
09/2016
1Dementia (Dementias)
09/2016
1Urinary Incontinence
03/2016
1Necrosis
11/2013

Drug/Important Bio-Agent (IBA)

5SesquiterpenesIBA
06/2022 - 01/2020
3Polycyclic SesquiterpenesIBA
06/2022 - 10/2020
3Pharmaceutical PreparationsIBA
06/2022 - 03/2016
3caryophyllene oxideIBA
11/2021 - 01/2019
3caryophylleneIBA
11/2021 - 01/2020
2Proteins (Proteins, Gene)FDA Link
06/2022 - 01/2019
2Sorafenib (BAY 43-9006)FDA Link
06/2022 - 01/2019
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2020
2AntioxidantsIBA
08/2018 - 01/2018
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
06/2022
1CannabidiolIBA
11/2021
1cannabichromeneIBA
11/2021
1humuleneIBA
11/2021
1CB2 Cannabinoid ReceptorIBA
11/2021
1Immunologic Factors (Immunomodulators)IBA
08/2020
1Prostaglandins EIBA
08/2019
1multidrug resistance-associated protein 1IBA
01/2019
1Antineoplastic Agents (Antineoplastics)IBA
01/2019
1Messenger RNA (mRNA)IBA
01/2019
1Adenosine Triphosphate (ATP)IBA
01/2019
1Liposomes (Liposome)IBA
12/2018
1Phosphatidylcholines (Phosphatidylcholine)IBA
12/2018
1Lactic Acid (Lactate)FDA LinkGeneric
08/2018
1Antiviral Agents (Antivirals)IBA
08/2018
1CurcuminIBA
09/2016
1ResveratrolIBA
09/2016
1oxybutynin (Tavor)FDA LinkGeneric
03/2016
1BilirubinIBA
11/2013
1Acetaminophen (Paracetamol)FDA LinkGeneric
11/2013

Therapy/Procedure

5Drug Therapy (Chemotherapy)
06/2022 - 01/2018
2Chemoprevention
10/2020 - 01/2020